Coca-Cola: Finally Turning Bullish Again
by JR Research
Contributor since 2021 / 19488 Followers
Contributor since 2021 / 19488 Followers
2 years ago
Summary: KO has fallen nearly 20% from its April highs, despite being regarded as a
3M: Risks Likely Baked In
by Jonathan Wheeler
Contributor since 2016 / 2785 Followers
Contributor since 2016 / 2785 Followers
2 years ago
Summary: There isn’t much to be positive on for 3M. Litigation risks and the macro
American Airlines Q3 Review: Stunner, Now Look Forward
by DM Martins Research
Contributor since 2015 / 20442 Followers
Contributor since 2015 / 20442 Followers
2 years ago
Summary: Not a surprise at all, American Airlines’ Q3 results were solid and fueled by
NextEra Energy: Still Overvalued After Its Recent Tumble – Don’t Buy The Dips
by JR Research
Contributor since 2021 / 20094 Followers
Contributor since 2021 / 20094 Followers
2 years ago
Summary: NEE has underperformed the broad market significantly since our previous Sell rating, as we
JPMorgan: A Powerful Engine Rumbles On
by Larry Hall
Contributor since 2018 / 1217 Followers
Contributor since 2018 / 1217 Followers
2 years ago
Summary: JPMorgan Chase & Co is an extremely powerful, consistent and successful financial institution. Its
AT&T And Comcast: These Discounts Won’t Last Long
by Sensor Unlimited
Contributor since 2021 / 5894 Followers
Contributor since 2021 / 5894 Followers
2 years ago
Summary: The Communication Services Sector represented by the Communication Services Select Sector SPDR Fund ‘XLC’
Lucid: After Recent Lows, Is The Stock A Buy?
by Mobility Matters Research
Contributor since 2020 / 6157 Followers
Contributor since 2020 / 6157 Followers
2 years ago
Summary: Lucid announced Q3 production and delivery figures, which, while showing meaningful growth from Q2’s
American Airlines: Q3 Could Impress, But Avoid The Stock
by DM Martins Research
Contributor since 2015 / 20442 Followers
Contributor since 2015 / 20442 Followers
2 years ago
Summary: American Airlines will report Q3 numbers on October 20, when it is well understood
Abercrombie & Fitch: Sharp Rallies Should Be Sold
by Taylor Dart
Contributor since 2016 / 26544 Followers
Contributor since 2016 / 26544 Followers
2 years ago
Summary: Abercrombie & Fitch released its Q2 results last week, reporting quarterly revenue of $805.1
Acadia Pharmaceuticals: Nuplazid’s (Pimavanserin) Last Hurrah
by Out of Ignorance
Contributor since 2016 / 6820 Followers
Contributor since 2016 / 6820 Followers
2 years ago
Summary: Once a proud pipeline in a molecule, NUPLAZID (pimavanserin) rests on its old standby